Literature DB >> 7063727

Nuclear magnetic resonance imaging and evaluation of human breast tissue: preliminary clinical trials.

R J Ross, J S Thompson, K Kim, R A Bailey.   

Abstract

In vivo clinical evaluations of human mammary tissue, including normal, dysplastic, and neoplastic breasts, were initiated using the FONAR method of nuclear magnetic resonance (NMR) imaging. Spin-lattice relaxation times (T1) were determined and correlated with other diagnostic modalities including mammography, xeroradiography, and sonography. Normal breasts and breasts with extensive fatty replacement were found to have the lowest T1 values, whereas T1 values of malignant tissue were elevated. T1 values for mammary dysplasia extended over a wide range, and NMR images exhibited lower proton density than normal tissue. In several patients with severely dysplastic breasts, T1 values overlapped those from patients with documented breast neoplasms. Markedly elevated T1 values were obtained from fluid-filled cysts that were well beyond the range of malignancy.

Entities:  

Mesh:

Year:  1982        PMID: 7063727     DOI: 10.1148/radiology.143.1.7063727

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Three-dimensional MR Fingerprinting for Quantitative Breast Imaging.

Authors:  Yong Chen; Ananya Panda; Shivani Pahwa; Jesse I Hamilton; Sara Dastmalchian; Debra F McGivney; Dan Ma; Joshua Batesole; Nicole Seiberlich; Mark A Griswold; Donna Plecha; Vikas Gulani
Journal:  Radiology       Date:  2018-10-30       Impact factor: 11.105

Review 2.  Breast cancer imaging: a perspective for the next decade.

Authors:  Andrew Karellas; Srinivasan Vedantham
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

Review 3.  Nuclear magnetic resonance imaging: a review.

Authors:  R G Henderson
Journal:  J R Soc Med       Date:  1983-03       Impact factor: 18.000

Review 4.  Imaging and cancer: a review.

Authors:  Leonard Fass
Journal:  Mol Oncol       Date:  2008-05-10       Impact factor: 7.449

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.